Individuals
Businesses
Company
Intelligence
News
African Capital Markets
EnglishEnglish
share on twittershare on linkedinshare on facebookshare to whatsapp
share on mail
share on instagram

SA healthtech RecoMed secures funding from Japanese pharma Eisai

Daba Finance/SA healthtech RecoMed secures funding from Japanese pharma Eisai
STARTUP VENTURE CAPITALMarch 7, 2024 at 9:47 PM UTC

TLDR

  • RecoMed secures funding from Eisai to support growth
  • Technology-driven healthcare platform connects patients and practitioners
  • Facilitates 250,000 patient visits and 100,000 bookings monthly

South African digital healthcare marketplace startup RecoMed has recently secured an undisclosed amount of funding from the Japanese pharmaceutical firm Eisai to fuel its ongoing growth trajectory.

RecoMed operates as a technology-driven online healthcare marketplace and booking platform, seamlessly connecting practitioners, patients, and other stakeholders within the healthcare ecosystem. Patients have the convenience of booking appointments with a diverse array of healthcare practitioners in their vicinity, accessible via phone, tablet, or PC.

The platform also serves as a valuable resource for healthcare providers, granting them access to volume-generating patient bookings sourced from various integrated channels such as web searches, medical aids, and life insurers. RecoMed claims to facilitate over 250,000 unique patient visits monthly and successfully confirms over 100,000 bookings each month.

Key Takeaways

One of the most significant trends in African tech in recent years has been the notable increase in investment from Asian powerhouses, particularly China. This surge in interest has expanded the funding options for African startups, which had traditionally relied on Silicon Valley and European venture capital firms. However, this trend is now diversifying further with growing interest from Japan, where a mix of early-stage and corporate venture capital investors are exploring opportunities on the continent. In addition to AAIC and SBI's support for Novastar, other Japanese entities are entering the African tech landscape. Kepple Africa Ventures boasts a portfolio of more than 100 African companies and manages the $100 million Verod-Kepple Africa Ventures fund. Uncovered Fund, founded in Tokyo in 2019, has invested in 26 African startup companies.

RecoMed
Eisai
Venture Capital
Venture Funding
South Africa
Healthcare
Healthech
Startups

Think someone else should see this?

share on twittershare on linkedinshare on facebookshare to whatsapp
share on mail
share on instagram
Stay informed with our newsletters read by 25,000+ professionals worldwide
Newsletter companiesNewsletter companiesNewsletter companiesNewsletter companiesNewsletter companiesNewsletter companies

Next Frontier

Stay up to date on major news and events in African markets. Delivered weekly.

Pulse54

UDeep-dives into what’s old and new in Africa’s investment landscape. Delivered twice monthly.

Events

Sign up to stay informed about our regular webinars, product launches, and exhibitions.

+25k investors have already subscribed

To invest in this opportunity and other opportunities across Africa

Download the daba finance app on your mobile through
appstore iconappstore icon
Phone Image

Take action.

Download app

Start investing in Africa’s best opportunities, including stocks, bonds, startups, venture funds, and more.

Partner with us

Unlock exciting business opportunities and growth potential.

Join Daba

Become a part of our vibrant community and enjoy exclusive benefits.

Contact us

Reach out to us for inquiries, support, or collaboration.
For Investor
StrategiesPortfolio ManagementAfrican Capital MarketsNews
Daba Pro Intelligence
For Capital Seekers
For StartupsFor Fund ManagersFor Private CompaniesFor Lenders
For Partners
Commercial BanksBroker DealersAsset ManagersInvestment BanksInvestment Advisors and ConsultantsLenders and Microfinance
Company
About UsMarket UpdatesEventsBlog and PodcastNewsletterCase StudiesAffiliate ProgramInvesting GlossaryOfficial ContactsTrust, Compliance and SecurityFrequently Asked Questions

Terms & ConditionsPrivacy Policy
EnglishEnglish

Owned by Daba Markets Inc. By using this site, you accept our Terms and Conditions and Privacy Policy. © 2024 All rights reserved. 2025 All rights reserved